Skip to main content

Advertisement

Log in

A role for interleukin-22 in the alleviation of metabolic syndrome

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Increasing evidence points to a role for the immune system in the regulation of metabolism. Two new studies in mice indicate treatment with interleukin-22 restores mucosal immunity in diabetes and alleviates metabolic disease, resulting in improved glycemic control.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: The effects of IL-22.

Katie Vicari/Nature Publishing Group

References

  1. Donath, M.Y. Nat. Rev. Drug Discov. 13, 465–476 (2014).

    Article  CAS  Google Scholar 

  2. Hasnain, S.Z. et al. Nat. Med. 20, doi:10.1038/nm.3705 (2 November 2014).

  3. Wang, X. et al. Nature 514, 237–241 (2014).

    Article  CAS  Google Scholar 

  4. Cani, P.D., Geurts, L., Matamoros, S., Plovier, H. & Duparc, T. Diabetes Metab. 40, 246–257 (2014).

    Article  CAS  Google Scholar 

  5. Tremaroli, V. & Backhed, F. Nature 489, 242–249 (2012).

    Article  CAS  Google Scholar 

  6. Colonna, M. Immunity 31, 15–23 (2009).

    Article  CAS  Google Scholar 

  7. Maedler, K. et al. J. Clin. Invest. 110, 851–860 (2002).

    Article  CAS  Google Scholar 

  8. Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Nat. Immunol. 11, 136–140 (2010).

    Article  CAS  Google Scholar 

  9. Sabat, R., Ouyang, W. & Wolk, K. Nat. Rev. Drug Discov. 13, 21–38 (2014).

    Article  CAS  Google Scholar 

  10. Winer, S. et al. Nat. Med. 15, 921–929 (2009).

    Article  CAS  Google Scholar 

  11. Dalmas, E. et al. Diabetes 63, 1966–1977 (2014).

    Article  CAS  Google Scholar 

  12. Fabbrini, E. et al. Gastroenterology 145, 366–374. e1–e3 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marc Y Donath.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dalmas, E., Donath, M. A role for interleukin-22 in the alleviation of metabolic syndrome. Nat Med 20, 1379–1381 (2014). https://doi.org/10.1038/nm.3748

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3748

  • Springer Nature America, Inc.

This article is cited by

Navigation